UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029876
Receipt number R000034118
Scientific Title Development of Safe Peri-operative Management for Surgical Patients using Body Composition Analyser
Date of disclosure of the study information 2017/11/09
Last modified on 2019/05/13 10:30:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of Safe Peri-operative Management for Surgical Patients using Body Composition Analyser

Acronym

InBody and Preoperative Management

Scientific Title

Development of Safe Peri-operative Management for Surgical Patients using Body Composition Analyser

Scientific Title:Acronym

InBody and Preoperative Management

Region

Japan


Condition

Condition

Cancer

Classification by specialty

Hematology and clinical oncology Surgery in general Hepato-biliary-pancreatic surgery
Chest surgery Breast surgery Operative medicine
Blood transfusion Intensive care medicine Rehabilitation medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Surgical interventions and chemotherapy affect the body composition of patients, depending on the target organs, surgical techniques, stage of the disease and fluid/nutrition management. The change in the body composition is one of the important factors to influence the post operative recovery and complication rate. In this study, we plan to measure the body composition of patients in both inpatient and outpatient settings in Kawasaki Medical School General Medical Centre, using InBody 770&S1, which are highly sophisticated non-invasive body composition analysers involving bioelectrical impedance. Our aim is to investigate if the body composition analysis would become a safe and efficient assessment tool for peri-operative management of surgical patients.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Post operative complications based on Clavien-Dindo classification

Key secondary outcomes

Other adverse event based on CTCAEv4.0, duration of stay in ICU, other clinical information from medical records


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <

Age-upper limit

20 years-old >=

Gender

Male and Female

Key inclusion criteria

All surgical patients who undergo operations and/or are receiving chemotherapy at Kawasaki Medical School General Medical Centre

Key exclusion criteria

Anyone not include above

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Tomoki
Middle name
Last name Yamatuji

Organization

Kawasaki Medical School

Division name

Department of General Surgery

Zip code

700-8505

Address

2-6-1, Nakasange, Kita-Ward, Okayama-City, Okayama-Prefecture

TEL

0862252111

Email

yama-t@med.kawasaki-m.ac.jp


Public contact

Name of contact person

1st name Tomoki
Middle name
Last name Yamatuji

Organization

Kawasaki Medical School

Division name

Department of General Surgery

Zip code

700-8505

Address

2-6-1, Nakasange, Kita-Ward, Okayama-City, Okayama-Prefecture

TEL

0862252111

Homepage URL


Email

yama-t@med.kawasaki-m.ac.jp


Sponsor or person

Institute

Kawasaki Medical School
Department of General Surgery

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kawasaki Medical School Hospital Ethics Committee

Address

577 Matsushima Kurashiki City Okayama Prefecture

Tel

086-464-1076

Email

kmsrec@med.kawasaki-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 11 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2017 Year 08 Month 02 Day

Date of IRB

2017 Year 08 Month 10 Day

Anticipated trial start date

2017 Year 08 Month 02 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Non applicable


Management information

Registered date

2017 Year 11 Month 08 Day

Last modified on

2019 Year 05 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034118


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name